Evaluation of macular thickness and volume tested by optical coherence tomography as biomarkers for Alzheimer’s disease in a memory clinic

  • 1.

    Beach, T. G., Monsell, S. E., Phillips, L. E. & Kukull, W. Accuracy of the Clinical Diagnosis of Alzheimer Disease at National Institute on Aging Alzheimer Disease Centers, 2005–2010. J. Neuropathol. Exp. Neurol. 71, 266–273 (2012).

  • 2.

    Morris, J. C. et al. Mild Cognitive Impairment Represents Early-Stage Alzheimer Disease. Arch. Neurol. 58, 124–129 (2001).

  • 3.

    Bondi, M. W. et al. Neuropsychological Criteria for Mild Cognitive Impairment Improves Diagnostic Precision, Biomarker Associations, and Progression Rates. J. Alzheimers. Dis. 42, 275–289 (2014).

  • 4.

    Petersen, R. C. et al. Mild cognitive impairment: A concept in evolution. J. Intern. Med. 275, 214–228 (2014).

  • 5.

    Espinosa, A. et al. A longitudinal follow-up of 550 mild cognitive impairment patients: evidence for large conversion to dementia rates and detection of major risk factors involved. J. Alzheimers. Dis. 34, 769–780…

  • Read more…